GL701: Began Phase II/III trial

Genelabs Technologies Inc. (GNLB), Redwood City, Calif. Product: GL701 dehydroepiandrosterone (DHEA), a steroid precursor that may work through cytokines and lacks the side effects of corticosteroids...